Early and strong antibody responses to SARS-CoV-2 predict disease severity in COVID-19 patients
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1479-5876
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Early and strong antibody responses to SARS-CoV-2 predict disease severity in COVID-19 patients ; volume:20 ; number:1 ; day:15 ; month:4 ; year:2022 ; pages:1-12 ; date:12.2022
Journal of translational medicine ; 20, Heft 1 (15.4.2022), 1-12, 12.2022
- Creator
-
Plūme, Jānis
Galvanovskis, Artis
Šmite, Sindija
Romanchikova, Nadezhda
Zayakin, Pawel
Linē, Aija
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s12967-022-03382-y
- URN
-
urn:nbn:de:101:1-2022063020065658857870
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:22 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Plūme, Jānis
- Galvanovskis, Artis
- Šmite, Sindija
- Romanchikova, Nadezhda
- Zayakin, Pawel
- Linē, Aija
- SpringerLink (Online service)
Other Objects (12)
A stronger antibody response in increased disease severity of SARS-CoV-2
Can inflammatory plasma proteins predict Long COVID or fatigue severity after SARS-CoV-2 infection?
Circulating proteins to predict COVID-19 severity
Antibody attributes that predict the neutralization and effector function of polyclonal responses to SARS-CoV-2
IgG antibody titers against SARS-CoV-2 nucleocapsid protein correlate with the severity of COVID-19 patients
Could Eosinophilia predict clinical severity in nasal polyps?
Development of a bedside score to predict dengue severity
Serum biomarkers associated with SARS-CoV-2 severity
Neutralizing antibody titres in SARS-CoV-2 infections
The early antibody response to SARS-Cov-2 infection
Antibody-mediated enhancement aggravates chikungunya virus infection and disease severity
Copeptin does not accurately predict disease severity in imported malaria
A stronger antibody response in increased disease severity of SARS-CoV-2
Can inflammatory plasma proteins predict Long COVID or fatigue severity after SARS-CoV-2 infection?
Circulating proteins to predict COVID-19 severity
Antibody attributes that predict the neutralization and effector function of polyclonal responses to SARS-CoV-2
IgG antibody titers against SARS-CoV-2 nucleocapsid protein correlate with the severity of COVID-19 patients
Could Eosinophilia predict clinical severity in nasal polyps?
Development of a bedside score to predict dengue severity
Serum biomarkers associated with SARS-CoV-2 severity
Neutralizing antibody titres in SARS-CoV-2 infections
The early antibody response to SARS-Cov-2 infection
Antibody-mediated enhancement aggravates chikungunya virus infection and disease severity
Copeptin does not accurately predict disease severity in imported malaria
A stronger antibody response in increased disease severity of SARS-CoV-2
Can inflammatory plasma proteins predict Long COVID or fatigue severity after SARS-CoV-2 infection?
Circulating proteins to predict COVID-19 severity
Antibody attributes that predict the neutralization and effector function of polyclonal responses to SARS-CoV-2
IgG antibody titers against SARS-CoV-2 nucleocapsid protein correlate with the severity of COVID-19 patients
Could Eosinophilia predict clinical severity in nasal polyps?
Development of a bedside score to predict dengue severity
Serum biomarkers associated with SARS-CoV-2 severity
Neutralizing antibody titres in SARS-CoV-2 infections
The early antibody response to SARS-Cov-2 infection
Antibody-mediated enhancement aggravates chikungunya virus infection and disease severity